Tecentriq misses mark in ovarian cancer trial
admin 14th July 2020 Uncategorised 0The drug did not extend progression-free survival in patients with newly diagnosed advanced stage ovarian cancer
More: Tecentriq misses mark in ovarian cancer trial
Source: News